• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嗅觉功能障碍及其与帕金森病临床特征的关系。

Olfactory Dysfunction and Its Relationship With Clinical Features of Parkinson's Disease.

作者信息

Zhou Yangjie, He Runcheng, Zhao Yuwen, He Yan, Hu Yacen, Sun Qiying, Xu Qian, Tan Jieqiong, Yan Xinxiang, Tang Beisha, Guo Jifeng

机构信息

Department of Neurology, Xiangya Hospital, Central South University, Changsha, China.

Department of Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.

出版信息

Front Neurol. 2020 Oct 16;11:526615. doi: 10.3389/fneur.2020.526615. eCollection 2020.

DOI:10.3389/fneur.2020.526615
PMID:33178098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7596377/
Abstract

To conduct an investigation into the reliability of assessing the olfactory function of patients with Parkinson's disease (PD) in a clinical setting of crowding patients in populated countries, such as China, by the hyposmia rating scale (HRS) and compare other non-motor features between patients with PD with olfactory dysfunction (PD-OD) and patients with PD without olfactory dysfunction (PD-NOD), according to the result of olfactory function assessed by the Sniffin' Sticks test. A total of 320 patients with clinically confirmed or clinically possible PD were recruited. Olfactory function of all participants was assessed with the HRS and the Sniffin' Sticks test. Demographic data and clinical information were collected, and patients were evaluated using standardized assessment protocols. With reference to the Sniffin' Sticks test, the specificity, sensitivity, coincidence rate, and kappa value of the HRS was computed, and then its reliability was evaluated. We divided patients into PD-OD and PD-NOD groups based on the results of olfactory function assessed by the Sniffin' Sticks test. Clinical manifestations were compared between PD-OD and PD-NOD. The percentage of patients with OD determined by the Sniffin' Sticks test was 65.6%, and the percentage of those with OD was 55.6% when using the HRS measured olfactory function. With reference to the Sniffin' Sticks test, the specificity, sensitivity, coincidence rate, and kappa value of the HRS were 82.73, 75.71, 78.13%, and 0.55, respectively. The area under the receiver operating characteristic curve for the HRS was 0.793. There were no differences in demographic characteristics between the PD-OD and PD-NOD groups. The patients with hyposmia had more severe non-motor symptoms. The HRS is of great value as a self-assessment scale for evaluating olfactory function, especially in PD patients over 55 years old. Moreover, PD patients with hyposmia have more severe non-motor features than PD patients without hyposmia, mainly in terms of mood and constipation.

摘要

为了在中国等人口众多国家拥挤的临床环境中,通过嗅觉减退评分量表(HRS)调查评估帕金森病(PD)患者嗅觉功能的可靠性,并根据Sniffin' Sticks测试评估的嗅觉功能结果,比较嗅觉功能障碍的PD患者(PD-OD)和无嗅觉功能障碍的PD患者(PD-NOD)之间的其他非运动特征。共招募了320例临床确诊或临床疑似PD患者。所有参与者的嗅觉功能均通过HRS和Sniffin' Sticks测试进行评估。收集人口统计学数据和临床信息,并使用标准化评估方案对患者进行评估。参照Sniffin' Sticks测试结果,计算HRS的特异性、敏感性、符合率和kappa值,进而评估其可靠性。根据Sniffin' Sticks测试评估的嗅觉功能结果,将患者分为PD-OD组和PD-NOD组。比较PD-OD组和PD-NOD组的临床表现。Sniffin' Sticks测试确定的嗅觉功能障碍患者百分比为65.6%,使用HRS测量嗅觉功能时为55.6%。参照Sniffin' Sticks测试,HRS的特异性、敏感性、符合率和kappa值分别为82.73、75.71、78.13%和0.55。HRS的受试者工作特征曲线下面积为0.793。PD-OD组和PD-NOD组在人口统计学特征上无差异。嗅觉减退的患者有更严重的非运动症状。HRS作为评估嗅觉功能的自我评估量表具有重要价值,尤其是对于55岁以上的PD患者。此外,嗅觉减退的PD患者比无嗅觉减退的PD患者有更严重的非运动特征,主要体现在情绪和便秘方面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8033/7596377/6cd813dc0d53/fneur-11-526615-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8033/7596377/a3f87879db51/fneur-11-526615-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8033/7596377/6cd813dc0d53/fneur-11-526615-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8033/7596377/a3f87879db51/fneur-11-526615-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8033/7596377/6cd813dc0d53/fneur-11-526615-g0002.jpg

相似文献

1
Olfactory Dysfunction and Its Relationship With Clinical Features of Parkinson's Disease.嗅觉功能障碍及其与帕金森病临床特征的关系。
Front Neurol. 2020 Oct 16;11:526615. doi: 10.3389/fneur.2020.526615. eCollection 2020.
2
Olfactory Dysfunction and Its Relationship with Clinical Symptoms of Alzheimer Disease.嗅觉功能障碍及其与阿尔茨海默病临床症状的关系。
Aging Dis. 2018 Dec 4;9(6):1084-1095. doi: 10.14336/AD.2018.0819. eCollection 2018 Dec.
3
Validation of a new scale to assess olfactory dysfunction in patients with Parkinson's disease.评估帕金森病患者嗅觉障碍的新量表的验证。
Parkinsonism Relat Disord. 2012 May;18(4):358-61. doi: 10.1016/j.parkreldis.2011.12.001. Epub 2012 Jan 5.
4
[Clinical application of Sniffin' Sticks olfactory psychophysical measurements].[嗅觉棒嗅觉心理物理学测量的临床应用]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2013 Sep;48(9):741-5.
5
Odor Identification by Parkinson's Disease Patients Tested by Using Sniffin' Sticks versus Natural Spices.使用嗅觉棒与天然香料对帕金森病患者进行气味识别测试
Parkinsons Dis. 2022 Apr 28;2022:2272691. doi: 10.1155/2022/2272691. eCollection 2022.
6
Identifying the potential role of serum miR-20a as a biomarker for olfactory dysfunction in patients with Parkinson's disease.鉴定血清 miR-20a 作为帕金森病患者嗅觉功能障碍的生物标志物的潜在作用。
Eur Arch Otorhinolaryngol. 2023 Oct;280(10):4509-4517. doi: 10.1007/s00405-023-08034-5. Epub 2023 Jun 1.
7
Self-assessment of olfactory function using the "Sniffin' Sticks".使用“嗅棒”进行嗅觉功能的自我评估。
Eur Arch Otorhinolaryngol. 2023 Aug;280(8):3673-3685. doi: 10.1007/s00405-023-07872-7. Epub 2023 Feb 17.
8
Investigation of the Sniffin' Sticks olfactory test in Taiwan and comparison with different continents.探讨 Sniffin' Sticks 嗅觉测试在台湾地区的应用,并与其他不同大陆地区进行比较。
J Chin Med Assoc. 2010 Sep;73(9):483-6. doi: 10.1016/S1726-4901(10)70103-9.
9
Invalid Self-Assessment of Olfactory Functioning in Parkinson's Disease Patients May Mislead the Neurologist.帕金森病患者对嗅觉功能的自我评估无效可能会误导神经科医生。
Parkinsons Dis. 2020 Nov 16;2020:7548394. doi: 10.1155/2020/7548394. eCollection 2020.
10
Olfactory Dysfunction and Its Association With Neuropathologic Proteins in Cerebrospinal Fluid From Patients With Parkinson Disease.嗅觉功能障碍及其与帕金森病患者脑脊液中神经病理蛋白的关联。
Front Aging Neurosci. 2020 Dec 11;12:594324. doi: 10.3389/fnagi.2020.594324. eCollection 2020.

引用本文的文献

1
Development and validation of a Wechat mini app-based screening tool (eR-BFAS) for early detection of Parkinson's disease.基于微信小程序的帕金森病早期检测筛查工具(eR-BFAS)的开发与验证
Aging Clin Exp Res. 2025 Jul 9;37(1):209. doi: 10.1007/s40520-025-03113-5.
2
Mutational spectrum and clinical features of GBA1 variants in a Chinese cohort with Parkinson's disease.中国帕金森病队列中GBA1基因变异的突变谱及临床特征
NPJ Parkinsons Dis. 2023 Sep 1;9(1):129. doi: 10.1038/s41531-023-00571-4.
3
α-Synuclein Pathology and Reduced Neurogenesis in the Olfactory System Affect Olfaction in a Mouse Model of Parkinson's Disease.

本文引用的文献

1
Regulation of immune-driven pathogenesis in Parkinson's disease by gut microbiota.肠道微生物群调节帕金森病中的免疫驱动发病机制。
Brain Behav Immun. 2020 Jul;87:890-897. doi: 10.1016/j.bbi.2020.01.009. Epub 2020 Jan 10.
2
Entorhinal Cortex Atrophy in Early, Drug-naive Parkinson's Disease with Mild Cognitive Impairment.早期未用药的轻度认知障碍帕金森病患者的内嗅皮质萎缩
Aging Dis. 2019 Dec 1;10(6):1221-1232. doi: 10.14336/AD.2018.1116. eCollection 2019 Dec.
3
Hyposmia as a marker of (non-)motor disease severity in Parkinson's disease.
α-突触核蛋白病理学和嗅觉系统中的神经发生减少会影响帕金森病小鼠模型的嗅觉。
J Neurosci. 2023 Feb 8;43(6):1051-1071. doi: 10.1523/JNEUROSCI.1526-22.2022. Epub 2023 Jan 3.
4
Association of Concurrent Olfactory Dysfunction and Probable Rapid Eye Movement Sleep Behavior Disorder with Early Parkinson's Disease Progression.嗅觉功能障碍并发可能的快速眼动睡眠行为障碍与早期帕金森病进展的关联
Mov Disord Clin Pract. 2022 Jul 22;9(7):909-919. doi: 10.1002/mdc3.13511. eCollection 2022 Oct.
嗅觉障碍作为帕金森病(非)运动疾病严重程度的标志物。
J Neural Transm (Vienna). 2019 Nov;126(11):1471-1478. doi: 10.1007/s00702-019-02074-0. Epub 2019 Sep 12.
4
Update of the MDS research criteria for prodromal Parkinson's disease.前驱帕金森病 MDS 研究标准的更新。
Mov Disord. 2019 Oct;34(10):1464-1470. doi: 10.1002/mds.27802. Epub 2019 Aug 14.
5
Expansion of Human-Specific GGC Repeat in Neuronal Intranuclear Inclusion Disease-Related Disorders.神经元核内包涵体病相关疾病中人类特异性 GGC 重复扩展。
Am J Hum Genet. 2019 Jul 3;105(1):166-176. doi: 10.1016/j.ajhg.2019.05.013. Epub 2019 Jun 6.
6
Factors Associated With Dyskinesia in Parkinson's Disease in Mainland China.中国大陆帕金森病异动症相关因素
Front Neurol. 2019 May 15;10:477. doi: 10.3389/fneur.2019.00477. eCollection 2019.
7
Clinical Features and Correlates of Excessive Daytime Sleepiness in Parkinson's Disease.帕金森病日间过度嗜睡的临床特征及相关因素
Front Neurol. 2019 Feb 19;10:121. doi: 10.3389/fneur.2019.00121. eCollection 2019.
8
Advances in the Research of Risk Factors and Prodromal Biomarkers of Parkinson's Disease.帕金森病危险因素和前驱生物标志物研究进展。
ACS Chem Neurosci. 2019 Feb 20;10(2):973-990. doi: 10.1021/acschemneuro.8b00520. Epub 2019 Jan 11.
9
Olfactory Dysfunction and Its Relationship with Clinical Symptoms of Alzheimer Disease.嗅觉功能障碍及其与阿尔茨海默病临床症状的关系。
Aging Dis. 2018 Dec 4;9(6):1084-1095. doi: 10.14336/AD.2018.0819. eCollection 2018 Dec.
10
Factors associated with depression in patients with Parkinson's disease A multicenter study in Lima, Peru.帕金森病患者抑郁相关因素:秘鲁利马的一项多中心研究
Dement Neuropsychol. 2018 Jul-Sep;12(3):292-298. doi: 10.1590/1980-57642018dn12-030010.